| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 05/09/2007 | CN1960727A Naphthalene derivatives useful as histamine-3-receptor ligands |
| 05/08/2007 | US7214803 Amidation of an alpha-pyrrolidinonylalkanoate by reaction with ammonium hydroxide |
| 05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 05/03/2007 | WO2007048595A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/03/2007 | CA2627234A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/03/2007 | CA2624676A1 Tyrosine kinase inhibitors |
| 05/02/2007 | EP1778643A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 04/26/2007 | WO2007045184A1 The peptides essence receptor antagonist which 2-site containing proline or crico-amino acid |
| 04/26/2007 | WO2007015263A3 Improved process for crystallization of benazepril hydrochloride |
| 04/26/2007 | US20070093379 Metal catalysts (preferably manganese-containing catalysts) complexed with selected macropolycyclic rigid ligands, preferably cross-bridged macropolycyclic ligands; useful for oxidative synthetic chemistry processes, bleaching of pulp and paper products |
| 04/25/2007 | EP1777222A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 04/25/2007 | CN1953963A Process for producing cyclic N-hydroxyimide compound |
| 04/25/2007 | CN1312133C Method for separating Beckmann rearrangement reaction products from ion liquid |
| 04/24/2007 | US7208630 Having a chimeric structure based, in part, on two naturally occurring Hsp90 inhibitors: radicicol ("RDC") and geldanamycin ("GDA"). |
| 04/24/2007 | US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 04/19/2007 | WO2007042657A1 $g(d)d crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 04/19/2007 | WO2007042656A1 Delta crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 04/18/2007 | EP1775288A1 Delta d Crystaline form of ivabradine hydrochloride, process of preparation thereof and pharmaceutical compositions containing the same |
| 04/18/2007 | EP1775287A1 Delta d Crystaline form of ivabradine hydrochloride, process of preparation thereof and pharmaceutical compositions containing the same |
| 04/18/2007 | EP1773779A1 Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 04/18/2007 | CN1948293A Delta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/18/2007 | CN1948292A Delta;-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/12/2007 | WO2007039138A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 04/12/2007 | US20070082886 bradycardial agent, myocardial ischaemia, angina pectoris, myocardial infarct and associated rhythm disturbances, supraventricular rhythm disturbances, and heart failure; mixture of acetonitrile and water is preheated, ivabradine hydrochloride is added, cooled at room temperature |
| 04/12/2007 | US20070082885 Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/12/2007 | CA2623114A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 04/11/2007 | EP1351938B1 Phenyl derivatives |
| 04/11/2007 | EP1084107B1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 04/11/2007 | EP0885180B1 Stabilized monomer composition |
| 04/11/2007 | CN1944411A Chemically synthetic method for N-chloroformyl imino dibenzyl |
| 04/11/2007 | CN1944410A Chemically synthetic method for N-chloroformyl imino dibenzyl |
| 04/05/2007 | WO2007037518A1 Mutilin derivative and pharmaceutical composition containing the same |
| 04/05/2007 | WO2006105304A3 Phenyl and pyridyl lta4h modulators |
| 04/05/2007 | WO2006056695A8 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
| 04/05/2007 | US20070078120 Novel piperidine derivative |
| 04/04/2007 | EP1768960A1 Sulfonamide derivatives |
| 04/04/2007 | CN1939918A Production of midanping |
| 04/04/2007 | CN1939908A Practical large ring lactam bactericide |
| 04/04/2007 | CN1308443C Preparation of lactams from aliphatic alpha, omega dinitriles |
| 04/04/2007 | CN1308313C Fused azepine drivatives and their use as antidiuretic agents |
| 04/04/2007 | CN1307875C Compounds, compositions, and methods for controlling biofilms |
| 03/29/2007 | WO2007035143A1 Stabilized protease composition |
| 03/29/2007 | WO2006029209A3 Method for activating trpv4 channel receptors by agonists |
| 03/29/2007 | US20070073057 Method for preparation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide |
| 03/29/2007 | US20070072875 Anti-inflammatory compositions and methods of use |
| 03/28/2007 | EP1765786A2 An improved process for the preparation of oxcarbazepine and related intermediates |
| 03/28/2007 | EP1765785A1 Prostaglandin analogs |
| 03/28/2007 | EP1138745B1 Organic electroluminescent element |
| 03/28/2007 | CN1307180C Method for extracting galanthamine from raw materials of genera of lycoris radiata or snowdrop |
| 03/28/2007 | CN1307157C Novel compounds |
| 03/28/2007 | CN1306935C Vasopressin antagonist and oxytocin antagonist |
| 03/27/2007 | US7196193 Reacting 2-(11H-dibenz[b,e]azepin-6-ylmethyl)-1H-isoindole-1,3(2H)-dione with a metal hydride or a metal hydride complex (sodium borohydride); antiallergic and antihistamine; hydrazine free |
| 03/27/2007 | US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases |
| 03/27/2007 | US7196099 Compounds and compositions as cathepsin inhibitors |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | US7195747 Process for mixing and reacting two or more fluids |
| 03/22/2007 | WO2007031429A1 Novel heterobicyclic derivatives useful as inhibitors of liver carnitine palmitoyl transferase |
| 03/22/2007 | US20070066594 Crystalline forms fenoldopam mesylate |
| 03/22/2007 | US20070065932 Bengamide derivatives, process for preparing them, and their use |
| 03/22/2007 | US20070065929 Bengamide derivatives, process for preparing them, and their use |
| 03/21/2007 | EP1763515A1 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 03/21/2007 | CN1934088A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/21/2007 | CN1933817A Disintegrating tablets comprising licarbazepine |
| 03/21/2007 | CN1305856C New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 03/21/2007 | CN1305855C Process for preparing epsilon-hexanolactam by catalyzing cyclohexanone-oxime rearranging |
| 03/20/2007 | US7192950 Psychological disorders; eating disorders; dietetics |
| 03/15/2007 | US20070060568 5HT2c receptor modulators |
| 03/15/2007 | US20070060567 Novel indolyl derivatives which are L-CPT1 inhibitors |
| 03/15/2007 | US20070060566 Benzazepine derivatives as histamine h3 antagonists |
| 03/14/2007 | EP1040103B1 Anilide derivative, production and use thereof |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/13/2007 | US7189846 Method for racemization of (S)-(+)- and (R)-(−)-10,11-dihydro-10-hydroxy-5h-dibenz[B,F]azepine-5-carboxamide and optically enriched mixtures thereof |
| 03/13/2007 | US7189845 Method for producing ε-caprolactam |
| 03/13/2007 | CA2267224C Vitronectin receptor antagonists |
| 03/08/2007 | WO2007028131A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 03/08/2007 | WO2007028083A2 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | WO2007028082A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | WO2007027719A2 Lisofylline analogues and their pharmeacuetical uses |
| 03/08/2007 | WO2007026971A2 Process for preparing benzazepine compounds or salts thereof |
| 03/08/2007 | WO2007026654A1 Enamide and process for producing the same, and dienamide and process for producing the same |
| 03/08/2007 | WO2007026224A2 5-ht1b antagonist composition for depression, anxiety and cognition |
| 03/08/2007 | WO2007025709A2 Organic compounds |
| 03/08/2007 | US20070054893 Prostaglandin analogs |
| 03/08/2007 | CA2620222A1 Organic compounds |
| 03/08/2007 | CA2619566A1 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619450A1 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619448A1 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2619287A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/08/2007 | CA2618970A1 Lisofylline analogs and methods for use |
| 03/07/2007 | EP1758867A1 Process for preparing oxcarbazepine |
| 03/07/2007 | CN1926240A Biochemical synthesis of 6-amino caproic acid |
| 03/07/2007 | CN1303084C New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 03/01/2007 | WO2007024612A2 8-substituted benzoazepines as toll-like receptor modulators |
| 03/01/2007 | WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors |
| 03/01/2007 | US20070049750 Method for synthesizing spiro quartenary ammonium systems |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | CA2619581A1 8-substituted benzoazepines as toll-like receptor modulators |
| 02/28/2007 | EP1757670A2 Organic electroluminescent element |
| 02/28/2007 | EP1757608A1 New benzazepine derivatives, medicaments containing the same and their use in the preparation of medicaments |